pharma_company
stringclasses 562
values | brand_name_en
stringlengths 19
232
| generic_name_en
stringlengths 21
250
| substance_name_en
stringclasses 983
values | atc_code_raw
stringclasses 778
values | anatomical_desc
stringclasses 14
values | therapeutic_desc
stringclasses 82
values | pharmacological_desc
stringclasses 181
values | subpharmacological_desc
stringclasses 365
values | chemical_desc
stringclasses 636
values |
---|---|---|---|---|---|---|---|---|---|
Vetter Pharma Fertigung Gmbh
|
PUREGON INJECTION, SOLUTION PARENTERAL 833 [iU]/1mL 1.08 [iU]
|
FOLLITROPIN BETA INJECTION, SOLUTION PARENTERAL 833 [iU]/1mL 1.08 mL
|
FOLLITROPIN BETA
| null | null | null | null | null | null |
Caspian Tamin Co.
|
PLADIC INJECTION PARENTERAL 5 mg/1mL 2 mL
|
METOCLOPRAMIDE INJECTION PARENTERAL 5 mg/1mL 2 mL
|
METOCLOPRAMIDE
|
A03FA01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
PROPULSIVES
|
Propulsives
|
metoclopramide
|
Sina Darou Laboratories
|
RINOSALTIN SPRAY NASAL 0.65 % 20 mL
|
SODIUM CHLORIDE SPRAY NASAL 0.65 % 20 mL
|
SODIUM CHLORIDE
|
R01AX
|
RESPIRATORY SYSTEM
|
NASAL PREPARATIONS
|
DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
|
Other nasal preparations
| null |
Daana Pharma
|
NITROGLYCERIN TABLET, EXTENDED RELEASE ORAL 6.4 mg
|
NITROGLYCERIN TABLET, EXTENDED RELEASE ORAL 6.4 mg
|
NITROGLYCERIN
|
C01DA02
|
CARDIOVASCULAR SYSTEM
|
CARDIAC THERAPY
|
VASODILATORS USED IN CARDIAC DISEASES
|
Organic nitrates
|
glyceryl trinitrate
|
Pars Darou
|
CANAZOLE SOLUTION TOPICAL 1 % 20 mL
|
CLOTRIMAZOLE SOLUTION TOPICAL 1 % 20 mL
|
CLOTRIMAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
DEXTOPHAN SOLUTION, DROPS ORAL 4 mg/1mL 15 mL
|
DEXTROMETHORPHAN HYDROBROMIDE SOLUTION, DROPS ORAL 4 mg/1mL 15 mL
|
DEXTROMETHORPHAN HYDROBROMIDE
|
R05DA09
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS
|
Opium alkaloids and derivatives
|
dextromethorphan
|
Amin Pharmaceutical Co.
|
METHADONE TABLET ORAL 40 mg
|
METHADONE HYDROCHLORIDE TABLET ORAL 40 mg
|
METHADONE HYDROCHLORIDE
|
N07BC02
|
NERVOUS SYSTEM
|
OTHER NERVOUS SYSTEM DRUGS
|
DRUGS USED IN ADDICTIVE DISORDERS
|
Drugs used in opioid dependence
|
methadone
|
Pannoc
|
PANGEL GEL TOPICAL 5 % 60 g
|
BENZOYL PEROXIDE GEL TOPICAL 5 % 60 g
|
BENZOYL PEROXIDE
|
D10AE01
|
DERMATOLOGICALS
|
ANTI-ACNE PREPARATIONS
|
ANTI-ACNE PREPARATIONS FOR TOPICAL USE
|
Peroxides
|
benzoyl peroxide
|
Chemidarou
|
PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE
|
A02BC02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
pantoprazole
|
Hakim Pharmaceutical Co.
|
PENTAFIL TABLET, EXTENDED RELEASE ORAL 400 mg
|
PENTOXIFYLLINE TABLET, EXTENDED RELEASE ORAL 400 mg
|
PENTOXIFYLLINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
CLINDAMYCIN CREAM VAGINAL 2 % 40 g
|
CLINDAMYCIN (AS PHOSPHATE) CREAM VAGINAL 2 % 40 g
|
CLINDAMYCIN (AS PHOSPHATE)
|
G01AA10
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
|
ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
|
Antibiotics
|
clindamycin
|
Raha Pharmaceutical Isfahan Company
|
PARKOHEAL TABLET, EXTENDED RELEASE ORAL 100 mg/25 mg
|
LEVODOPA / CARBIDOPA TABLET, EXTENDED RELEASE ORAL 100 mg/25 mg
|
LEVODOPA / CARBIDOPA
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Raha Pharmaceutical Isfahan Company
|
DERMOPAN CREAM TOPICAL 5 % 30 g
|
DEXPANTHENOL CREAM TOPICAL 5 % 30 g
|
DEXPANTHENOL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pharmachemie
|
PHARMELA-P CREAM TOPICAL 2.5 %/2.5 % 30 g
|
LIDOCAINE / PRILOCAINE CREAM TOPICAL 2.5 %/2.5 % 30 g
|
LIDOCAINE / PRILOCAINE
|
N01BB52
|
NERVOUS SYSTEM
|
ANESTHETICS
|
ANESTHETICS, LOCAL
|
Amides
|
lidocaine, combinations
|
Darou Pakhsh
|
SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.9 % 500 mL
|
SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.9 % 500 mL
|
SODIUM CHLORIDE
|
B05XA03
|
BLOOD AND BLOOD FORMING ORGANS
|
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
|
I.V. SOLUTION ADDITIVES
|
Electrolyte solutions
|
sodium chloride
|
Tehran Chemie Pharmaceutical Co.
|
CLOMAZOL CREAM TOPICAL 1 % 15 g
|
CLOTRIMAZOLE CREAM TOPICAL 1 % 15 g
|
CLOTRIMAZOLE
|
D01AC01
|
DERMATOLOGICALS
|
ANTIFUNGALS FOR DERMATOLOGICAL USE
|
ANTIFUNGALS FOR TOPICAL USE
|
Imidazole and triazole derivatives
|
clotrimazole
|
Pooyesh Darou
|
PDPOETIN INJECTION PARENTERAL 20000 [iU]/1mL 0.5 [iU]
|
EPOETIN INJECTION PARENTERAL 20000 [iU]/1mL 0.5 mL
|
EPOETIN
|
B03XA01
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTIANEMIC PREPARATIONS
|
OTHER ANTIANEMIC PREPARATIONS
|
Other antianemic preparations
|
erythropoietin
|
Tasnim Pharmaceutical
|
PANTOPRAZOLE CAPSULE, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE CAPSULE, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE
|
A02BC02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
pantoprazole
|
Exir Pharmaceutical Company
|
SELECOXIR CAPSULE ORAL 200 mg
|
CELECOXIB CAPSULE ORAL 200 mg
|
CELECOXIB
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
IMIPRAMINE TABLET ORAL 25 mg
|
IMIPRAMINE HYDROCHLORIDE TABLET ORAL 25 mg
|
IMIPRAMINE HYDROCHLORIDE
|
N06AA02
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTIDEPRESSANTS
|
Non-selective monoamine reuptake inhibitors
|
imipramine
|
Osvah Pharmaceutical Co.
|
OSVE-CINNARIZINE TABLET ORAL 75 mg
|
CINNARIZINE TABLET ORAL 75 mg
|
CINNARIZINE
|
N07CA02
|
NERVOUS SYSTEM
|
OTHER NERVOUS SYSTEM DRUGS
|
ANTIVERTIGO PREPARATIONS
|
Antivertigo preparations
|
cinnarizine
|
null |
RIVAXON® 1.5MG CAP CAPSULE ORAL 1.5 mg
|
RIVASTIGMINE (AS HYDROGEN TARTRATE) CAPSULE ORAL 1.5 mg
|
RIVASTIGMINE (AS HYDROGEN TARTRATE)
|
N06DA03
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTI-DEMENTIA DRUGS
|
Anticholinesterases
|
rivastigmine
|
Karen Pharma & Food Supplement Co.
|
VALSARTAN TABLET ORAL 80 mg
|
VALSARTAN TABLET ORAL 80 mg
|
VALSARTAN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
VITAMIN B12 INJECTION PARENTERAL 1000 ug/1mL mL
|
VITAMIN B12 INJECTION PARENTERAL 1000 ug/1mL
|
VITAMIN B12
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
BIPERIDEN TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE
|
N04AA02
|
NERVOUS SYSTEM
|
ANTI-PARKINSON DRUGS
|
ANTICHOLINERGIC AGENTS
|
Tertiary amines
|
biperiden
|
Amin Pharmaceutical Co.
|
DILTIAZEM TABLET ORAL 60 mg
|
DILTIAZEM HYDROCHLORIDE TABLET ORAL 60 mg
|
DILTIAZEM HYDROCHLORIDE
|
C08DB01
|
CARDIOVASCULAR SYSTEM
|
CALCIUM CHANNEL BLOCKERS
|
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
|
Benzothiazepine derivatives
|
diltiazem
|
Loghman Pharmaceutical & Hygienic (public)
|
CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g g
|
CEFTRIAXONE (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g
|
CEFTRIAXONE (AS SODIUM)
|
J01DD04
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
OTHER BETA-LACTAM ANTIBACTERIALS
|
Third-generation cephalosporins
|
ceftriaxone
|
Farabi Pharmaceutical
|
AMOXICILLIN POWDER, FOR SUSPENSION ORAL 125 mg/5mL 100 mL
|
AMOXICILLIN POWDER, FOR SUSPENSION ORAL 125 mg/5mL 100 mL
|
AMOXICILLIN
|
J01CA04
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
BETA-LACTAM ANTIBACTERIALS, PENICILLINS
|
Penicillins with extended spectrum
|
amoxicillin
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
LORADINE SYRUP ORAL 5 mg/5 mL 60 mL
|
LORATADINE SYRUP ORAL 5 mg/5 mL 60 mL
|
LORATADINE
|
R06AX13
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Other antihistamines for systemic use
|
loratadine
|
Sina Darou Laboratories
|
NASOCALCIN SPRAY NASAL 200 [iU]/1{Puff} 14 {Puff}
|
CALCITONIN, SALMON SPRAY NASAL 200 [iU]/1{Puff} 14 {Puff}
|
CALCITONIN, SALMON
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
FENOPID CAPSULE ORAL 200 mg
|
FENOFIBRATE CAPSULE ORAL 200 mg
|
FENOFIBRATE
|
C10AB05
|
CARDIOVASCULAR SYSTEM
|
LIPID MODIFYING AGENTS
|
LIPID MODIFYING AGENTS, PLAIN
|
Fibrates
|
fenofibrate
|
Caspian Tamin Co.
|
PYROMOL INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 150 mg/1mL 6.7 g
|
ACETAMINOPHEN INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 150 mg/1mL 6.7 mL
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Daana Pharma
|
GELOFEN CAPSULE, LIQUID FILLED ORAL 200 mg
|
IBUPROFEN CAPSULE, LIQUID FILLED ORAL 200 mg
|
IBUPROFEN
|
M01AE01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Propionic acid derivatives
|
ibuprofen
|
Farabi Pharmaceutical
|
PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 40 mg
|
PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 40 mg
|
PANTOPRAZOLE
|
A02BC02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
pantoprazole
|
Hakim Pharmaceutical Co.
|
SITAGLIPTIN/METFORMIN TABLET ORAL 50 mg/500 mg
|
SITAGLIPTIN (AS PHOSPHATE) / METFORMIN HYDROCHLORIDE TABLET ORAL 50 mg/500 mg
|
SITAGLIPTIN (AS PHOSPHATE) / METFORMIN HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Arnikahealth Pharmaceutical Co
|
INDOMETHACIN SUPPOSITORY RECTAL 100 mg
|
INDOMETHACIN SUPPOSITORY RECTAL 100 mg
|
INDOMETHACIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
DIPHENHYDRAMINE SOLUTION ORAL 12.5 mg/5mL 60 mL
|
DIPHENHYDRAMINE HYDROCHLORIDE SOLUTION ORAL 12.5 mg/5mL 60 mL
|
DIPHENHYDRAMINE HYDROCHLORIDE
|
R06AA02
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Aminoalkyl ethers
|
diphenhydramine
|
Pharmachemie
|
IBUPROFEN SUSPENSION ORAL 100 mg/5mL 120 mL
|
IBUPROFEN SUSPENSION ORAL 100 mg/5mL 120 mL
|
IBUPROFEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Chemidarou
|
ACETAMINOPHEN TABLET ORAL 325 mg
|
ACETAMINOPHEN TABLET ORAL 325 mg
|
ACETAMINOPHEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Samen Pharmaceutical Co
|
SODIUM CHLORIDE SOLUTION IRRIGATION 0.9 % 500 mL
|
SODIUM CHLORIDE SOLUTION IRRIGATION 0.9 % 500 mL
|
SODIUM CHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hetero
|
FAVIVIR TABLET ORAL 200 mg
|
FAVIPIRAVIR TABLET ORAL 200 mg
|
FAVIPIRAVIR
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
AMITRIPTYLINE TABLET ORAL 25 mg
|
AMITRIPTYLINE HYDROCHLORIDE TABLET ORAL 25 mg
|
AMITRIPTYLINE HYDROCHLORIDE
|
N06AA09
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTIDEPRESSANTS
|
Non-selective monoamine reuptake inhibitors
|
amitriptyline
|
Razak Labratories
|
TETRACYCLINE OINTMENT TOPICAL 3 % 15 g
|
TETRACYCLINE HYDROCHLORIDE OINTMENT TOPICAL 3 % 15 g
|
TETRACYCLINE HYDROCHLORIDE
|
D06AA04
|
DERMATOLOGICALS
|
ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
|
ANTIBIOTICS FOR TOPICAL USE
|
Tetracycline and derivatives
|
tetracycline
|
Shahid Ghazi Pharmaceutical Co.
|
LINEZOLID INJECTION, SOLUTION PARENTERAL 2 mg/1mL 300 mL
|
LINEZOLID INJECTION, SOLUTION PARENTERAL 2 mg/1mL 300 mL
|
LINEZOLID
|
J01XX08
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
OTHER ANTIBACTERIALS
|
Other antibacterials
|
linezolid
|
Amin Pharmaceutical Co.
|
METOCLOPRAMIDE TABLET ORAL 10 mg
|
METOCLOPRAMIDE HYDROCHLORIDE TABLET ORAL 10 mg
|
METOCLOPRAMIDE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Najo
|
MINOXIDIL-NAJO SOLUTION TOPICAL 20 mg/1mL 60 mL
|
MINOXIDIL SOLUTION TOPICAL 20 mg/1mL 60 mL
|
MINOXIDIL
|
D11AX01
|
DERMATOLOGICALS
|
OTHER DERMATOLOGICAL PREPARATIONS
|
OTHER DERMATOLOGICAL PREPARATIONS
|
Other dermatologicals
|
minoxidil
|
World Medicine
|
DORZAMED SOLUTION, DROPS OPHTHALMIC 2 % 5 mL
|
DORZOLAMIDE (AS HYDROCHLORIDE) SOLUTION, DROPS OPHTHALMIC 2 % 5 mL
|
DORZOLAMIDE (AS HYDROCHLORIDE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Hormone
|
ANDOZIX-IH INJECTION PARENTERAL 250 mg/1mL mL
|
TESTOSTERONE ENANTHATE INJECTION PARENTERAL 250 mg/1mL
|
TESTOSTERONE ENANTHATE
|
G03BA03
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
|
ANDROGENS
|
3-oxoandrosten (4) derivatives
|
testosterone
|
Kwality Pharmaceuticals Ltd.
|
PERPHENAZINE TABLET ORAL 8 mg
|
PERPHENAZINE TABLET ORAL 8 mg
|
PERPHENAZINE
|
N05AB03
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Phenothiazines with piperazine structure
|
perphenazine
|
Iran Hormone
|
LIOTHYRONINE TABLET ORAL 25 ug
|
LIOTHYRONINE SODIUM TABLET ORAL 25 ug
|
LIOTHYRONINE SODIUM
|
H03AA02
|
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
THYROID THERAPY
|
THYROID PREPARATIONS
|
Thyroid hormones
|
liothyronine sodium
|
Teb-mofid-nikan
|
LOSARTAN TABLET ORAL 25 mg
|
LOSARTAN POTASSIUM TABLET ORAL 25 mg
|
LOSARTAN POTASSIUM
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
DICLOFENAC SUPPOSITORY RECTAL 100 mg
|
DICLOFENAC SODIUM SUPPOSITORY RECTAL 100 mg
|
DICLOFENAC SODIUM
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
PANTOPRAZOLE-SHAFA CAPSULE, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE CAPSULE, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Daana Pharma
|
GELOFEN CAPSULE, LIQUID FILLED ORAL 200 mg
|
IBUPROFEN CAPSULE, LIQUID FILLED ORAL 200 mg
|
IBUPROFEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Farabi Pharmaceutical
|
CO-AMOXICLAV TABLET ORAL 500 mg/125 mg
|
CO-AMOXICLAV TABLET ORAL 500 mg/125 mg
|
CO-AMOXICLAV
|
J01CR02
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
BETA-LACTAM ANTIBACTERIALS, PENICILLINS
|
Combinations of penicillins, incl. beta-lactamase inhibitors
|
amoxicillin and beta-lactamase inhibitor
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
FAMOTIDINE TABLET ORAL 40 mg
|
FAMOTIDINE TABLET ORAL 40 mg
|
FAMOTIDINE
|
A02BA03
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
H2-receptor antagonists
|
famotidine
|
Pharmachemie
|
LIDOPROX CREAM TOPICAL 2.5 %/2.5 % 30 g
|
LIDOCAINE / PRILOCAINE CREAM TOPICAL 2.5 %/2.5 % 30 g
|
LIDOCAINE / PRILOCAINE
|
N01BB52
|
NERVOUS SYSTEM
|
ANESTHETICS
|
ANESTHETICS, LOCAL
|
Amides
|
lidocaine, combinations
|
Amin Pharmaceutical Co.
|
SYNOMIX TABLET ORAL 5 mg/80 mg
|
AMLODIPINE (AS BESILATE) / VALSARTAN TABLET ORAL 5 mg/80 mg
|
AMLODIPINE (AS BESILATE) / VALSARTAN
|
C09DB01
|
CARDIOVASCULAR SYSTEM
|
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
|
ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
|
Angiotensin II receptor blockers (ARBs) and calcium channel blockers
|
valsartan and amlodipine
|
Baxter
|
FEIBA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU] [iU]
|
ACTIVATED PROTHROMBIN COMPLEX (CONCENTRATED) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU]
|
ACTIVATED PROTHROMBIN COMPLEX (CONCENTRATED)
|
B02BD03
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTIHEMORRHAGICS
|
VITAMIN K AND OTHER HEMOSTATICS
|
Blood coagulation factors
|
factor VIII inhibitor bypassing activity
|
Samen Pharmaceutical Co
|
LEVOFLOXACIN IN DEXTROSE INJECTION, SOLUTION INTRAVENOUS 5 mg/1mL 100 mL
|
LEVOFLOXACIN INJECTION, SOLUTION INTRAVENOUS 5 mg/1mL 100 mL
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Emad Darman Pars
|
GUAIFENESIN-EMAD SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Dr. Abidi Pharmaceuticals
|
VALZODEC-HCT TABLET ORAL 160 mg/12.5 mg
|
VALSARTAN / HYDROCHLOROTHIAZIDE TABLET ORAL 160 mg/12.5 mg
|
VALSARTAN / HYDROCHLOROTHIAZIDE
|
C09DA03
|
CARDIOVASCULAR SYSTEM
|
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
|
ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
|
Angiotensin II receptor blockers (ARBs) and diuretics
|
valsartan and diuretics
|
Exir Pharmaceutical Company
|
ENOXIR INJECTION PARENTERAL 100 mg/1mL 0.6 mL
|
ENOXAPARIN SODIUM INJECTION PARENTERAL 100 mg/1mL 0.6 mL
|
ENOXAPARIN SODIUM
|
B01AB05
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTITHROMBOTIC AGENTS
|
ANTITHROMBOTIC AGENTS
|
Heparin group
|
enoxaparin
|
Medispray
|
FLUTICORT PLUS AEROSOL, METERED RESPIRATORY 25 ug/125 ug/1{dose} 120 {dose}
|
SALMETEROL (AS XINAFOATE) / FLUTICASONE PROPIONATE AEROSOL, METERED RESPIRATORY 25 ug/125 ug/1{dose} 120 {dose}
|
SALMETEROL (AS XINAFOATE) / FLUTICASONE PROPIONATE
|
R03AK06
|
RESPIRATORY SYSTEM
|
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
ADRENERGICS, INHALANTS
|
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
|
salmeterol and fluticasone
|
Ronak Pharmaceutical
|
BERAKSURF INJECTION, SUSPENSION ENDOTRACHEAL 25 mg/1mL 8 mg
|
BERACTANT INJECTION, SUSPENSION ENDOTRACHEAL 25 mg/1mL 8 mL
|
BERACTANT
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
APIRAX TABLET ORAL 2.5 mg
|
APIXABAN TABLET ORAL 2.5 mg
|
APIXABAN
|
B01AF02
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTITHROMBOTIC AGENTS
|
ANTITHROMBOTIC AGENTS
|
Direct factor Xa inhibitors
|
apixaban
|
Sobhan Oncology
|
PACLITAXEL INJECTION PARENTERAL 6 mg/1mL 25 mL
|
PACLITAXEL INJECTION PARENTERAL 6 mg/1mL 25 mL
|
PACLITAXEL
|
L01CD01
|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
ANTINEOPLASTIC AGENTS
|
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
|
Taxanes
|
paclitaxel
|
Behvazan Pharmaceutical
|
POVIDONE IODINE-BEHVAZAN DOUCHE VAGINAL 10 % 250 mL
|
POVIDONE IODINE DOUCHE VAGINAL 10 % 250 mL
|
POVIDONE IODINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Raha Pharmaceutical Isfahan Company
|
FELAZON SPRAY NASAL 50 ug/1{Puff} 200 mL
|
FLUTICASONE PROPIONATE SPRAY NASAL 50 ug/1{Puff} 200 {Puff}
|
FLUTICASONE PROPIONATE
|
R01AD08
|
RESPIRATORY SYSTEM
|
NASAL PREPARATIONS
|
DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
|
Corticosteroids
|
fluticasone
|
Mehr Darou
|
SULFASALAZINE TABLET ORAL 500 mg
|
SULFASALAZINE TABLET ORAL 500 mg
|
SULFASALAZINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Razak Labratories
|
CLINDAPLUS GEL TOPICAL 1.2 %/0.025 % 30 g
|
CLINDAMYCIN PHOSPHATE / TRETINOIN GEL TOPICAL 1.2 %/0.025 % 30 g
|
CLINDAMYCIN PHOSPHATE / TRETINOIN
|
D10AF51
|
DERMATOLOGICALS
|
ANTI-ACNE PREPARATIONS
|
ANTI-ACNE PREPARATIONS FOR TOPICAL USE
|
Antiinfectives for treatment of acne
|
clindamycin, combinations
|
Ramopharmin
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Emad Darman Pars
|
DEXTROMETHORPHAN P-EMAD SYRUP ORAL 15 mg/30 mg/5mL mL
|
DEXTROMETHORPHAN / PSEUDOEPHEDRINE SYRUP ORAL 15 mg/30 mg/5mL
|
DEXTROMETHORPHAN / PSEUDOEPHEDRINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Zahravi Pharmaceutical
|
SULFASALAZINE TABLET, DELAYED RELEASE ORAL 500 mg
|
SULFASALAZINE TABLET, DELAYED RELEASE ORAL 500 mg
|
SULFASALAZINE
|
A07EC01
|
ALIMENTARY TRACT AND METABOLISM
|
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
|
INTESTINAL ANTIINFLAMMATORY AGENTS
|
Aminosalicylic acid and similar agents
|
sulfasalazine
|
Zagros Pharmed Pars Pharmaceutical Co
|
DIPIPENEM INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg/500 mg mg
|
IMIPENEM / CILASTATIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg/500 mg
|
IMIPENEM / CILASTATIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Kishmedipharm
|
CLOTRIMAZOLE MEDIPHARM CREAM VAGINAL 2 % 20 g
|
CLOTRIMAZOLE CREAM VAGINAL 2 % 20 g
|
CLOTRIMAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
ATENOLOL-SHAFA TABLET ORAL 50 mg
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL
|
C07AB03
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
atenolol
|
Soha Pharmaceutical Co.
|
FEXOFENADINE SOHA TABLET ORAL 180 mg
|
FEXOFENADINE HYDROCHLORIDE TABLET ORAL 180 mg
|
FEXOFENADINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
THEOPHYLLINE TABLET, EXTENDED RELEASE ORAL 200 mg
|
THEOPHYLLINE TABLET, EXTENDED RELEASE ORAL 200 mg
|
THEOPHYLLINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Emad Darman Pars
|
TRIAMCINOLONE NN-EMAD OINTMENT TOPICAL 1 mg/2.5 mg/100000 [iU]/1g 15 g
|
TRIAMCINOLONE NN OINTMENT TOPICAL 1 mg/2.5 mg/100000 [iU]/1g 15 g
|
TRIAMCINOLONE NN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Zahravi Pharmaceutical
|
DOMPERIDONE TABLET ORAL 10 mg
|
DOMPERIDONE TABLET ORAL 10 mg
|
DOMPERIDONE
|
A03FA03
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
PROPULSIVES
|
Propulsives
|
domperidone
|
Alhavi
|
PARAKID SUSPENSION ORAL 120 mg/5mL 120 mL
|
ACETAMINOPHEN SUSPENSION ORAL 120 mg/5mL 120 mL
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Daana Pharma
|
ACETAGEL CAPSULE, GELATIN COATED ORAL 325 mg
|
ACETAMINOPHEN CAPSULE, GELATIN COATED ORAL 325 mg
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Pursina Pharmaceutical Co.
|
SUMATRIPTAN TABLET ORAL 50 mg
|
SUMATRIPTAN (AS SUCCINATE) TABLET ORAL 50 mg
|
SUMATRIPTAN (AS SUCCINATE)
|
N02CC01
|
NERVOUS SYSTEM
|
ANALGESICS
|
ANTIMIGRAINE PREPARATIONS
|
Selective serotonin (5HT1) agonists
|
sumatriptan
|
Iran Hormone
|
ANDOZIX-IH INJECTION PARENTERAL 100 mg/1mL mL
|
TESTOSTERONE ENANTHATE INJECTION PARENTERAL 100 mg/1mL
|
TESTOSTERONE ENANTHATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pars Darou
|
CANAZOLE SOLUTION TOPICAL 1 % 20 mL
|
CLOTRIMAZOLE SOLUTION TOPICAL 1 % 20 mL
|
CLOTRIMAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Ge Healthcare
|
OMNIPAQUE INJECTION PARENTERAL 300 mg/1mL 50 mL
|
IOHEXOL INJECTION PARENTERAL 300 mg/1mL 50 mL
|
IOHEXOL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Laboratorio Reig Jofre S.a
|
NIMODIPINE ALTAN INJECTION, SOLUTION INTRAVENOUS 0.2 mg/1mL 50 mg
|
NIMODIPINE INJECTION, SOLUTION INTRAVENOUS 0.2 mg/1mL 50 mL
|
NIMODIPINE
|
C08CA06
|
CARDIOVASCULAR SYSTEM
|
CALCIUM CHANNEL BLOCKERS
|
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
|
Dihydropyridine derivatives
|
nimodipine
|
Fanavarihaye Novin Darouie Atieh
|
EXIRECT TABLET ORAL 30 mg
|
DAPOXETINE (AS HYDROCHLORIDE) TABLET ORAL 30 mg
|
DAPOXETINE (AS HYDROCHLORIDE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Najo
|
CLO-GYN SUPPOSITORY VAGINAL 100 mg
|
CLOTRIMAZOLE SUPPOSITORY VAGINAL 100 mg
|
CLOTRIMAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Loghman Pharmaceutical & Hygienic (public)
|
MELOXICAM TABLET ORAL 15 mg
|
MELOXICAM TABLET ORAL 15 mg
|
MELOXICAM
|
M01AC06
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Oxicams
|
meloxicam
|
Cosar Pharmaceutical
|
CO-AMOXICLAV TABLET ORAL 500 mg/125 mg
|
CO-AMOXICLAV TABLET ORAL 500 mg/125 mg
|
CO-AMOXICLAV
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Teb-mofid-nikan
|
DRASTIFEN TABLET, EXTENDED RELEASE ORAL 800 mg
|
IBUPROFEN TABLET, EXTENDED RELEASE ORAL 800 mg
|
IBUPROFEN
| null | null | null | null | null | null |
Ronak Pharmaceutical
|
DECARELIN INJECTION PARENTERAL 95.6 ug mg
|
TRIPTORELIN (AS ACETATE) INJECTION PARENTERAL 95.6 ug
|
TRIPTORELIN (AS ACETATE)
|
L02AE04
|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
ENDOCRINE THERAPY
|
HORMONES AND RELATED AGENTS
|
Gonadotropin releasing hormone analogues
|
triptorelin
|
Tehran Chemie Pharmaceutical Co.
|
NIMUSCAR TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE
|
N04AA02
|
NERVOUS SYSTEM
|
ANTI-PARKINSON DRUGS
|
ANTICHOLINERGIC AGENTS
|
Tertiary amines
|
biperiden
|
Arimed
|
TEKAVENT POWDER, METERED RESPIRATORY 400 ug/1{dose} 60 ug
|
BUDESONIDE POWDER, METERED RESPIRATORY 400 ug/1{dose} 60 {dose}
|
BUDESONIDE
|
R03BA02
|
RESPIRATORY SYSTEM
|
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
|
Glucocorticoids
|
budesonide
|
Darou Pakhsh
|
ACETAMINOPHEN SOLUTION, DROPS ORAL 100 mg/1mL 15 mL
|
ACETAMINOPHEN SOLUTION, DROPS ORAL 100 mg/1mL 15 mL
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Afachemi
|
AFAXON INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g g
|
CEFTRIAXONE (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g
|
CEFTRIAXONE (AS SODIUM)
|
J01DD04
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
OTHER BETA-LACTAM ANTIBACTERIALS
|
Third-generation cephalosporins
|
ceftriaxone
|
Donyaye Behdasht Labs.co
|
MUTISIN SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN
|
R05CA03
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
|
Expectorants
|
guaifenesin
|
Pars Darou
|
METROVAGE GEL VAGINAL 0.75 % 70 g
|
METRONIDAZOLE GEL VAGINAL 0.75 % 70 g
|
METRONIDAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.